The attorneys of Arnall Golden Gregory’s Food and Drug Practice invite you to attend a complimentary webinar “FDA Stops Being Antisocial – Recent Social Media Guidance Breaks the Silence.”
On January 13, FDA released long-awaited guidance on using social media to promote prescription drugs. The guidance outlines FDA’s expectations for when and how a company should submit such “interactive promotional media” to the agency pursuant to postmarketing submission requirements.
Register now to hear AGG’s Food and Drug Practice leader, Alan Minsk address questions such as:
- Who influences or controls the message?
- When should I submit a 2253?
- Am I responsible if someone comments on our website?
- What do we need to do differently?
Please direct any questions regarding the webinar to Tracey Chapman, 404.870.5684.